Narciclasine inhibits vaccinia virus infection by activating the RhoA signaling pathway
In 2022, a sharp rise in global cases of mpox virus (MPXV) led the World Health Organization (WHO) to declare it a public health emergency of international concern. However, progress in developing drugs targeting MPXV has been slow. Here, we investigate the natural alkaloid narciclasine as a potenti...
Saved in:
| Main Authors: | Ting Xu, Zhengyang Pan, Xue Li, Mengyang Zhao, Zichen Li, Leiliang Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Biosafety and Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590053624001332 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Host RhoA Signaling Controls Filamentous vs. Spherical Morphogenesis and Cell-to-Cell Spread of RSV via Lipid Raft Localization: Host-Directed Antiviral Target
by: Manoj K. Pastey, et al.
Published: (2025-07-01) -
Temporal expression classes and functions of vaccinia virus and mpox (monkeypox) virus genes
by: Yining Deng, et al.
Published: (2025-04-01) -
Effect of alpha-linolenic acid on aminoglycoside nephrotoxicity and RhoA/Rho-kinase pathway in kidney
by: Percin Pazarci, et al.
Published: (2024-10-01) -
Pathogenic single nucleotide polymorphisms in RhoA gene: Insights into structural and functional impacts on RhoA-PLD1 interaction through molecular dynamics simulation
by: Mahbub Hasan, et al.
Published: (2024-01-01) -
Understanding mpox - A resurgent global health challenge
by: Supriya Satish Patil
Published: (2024-07-01)